Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

RICORS-ICTUS

IP: Anna Rosell Novel
Collaborators: Marcel Lamana Vallverdu, Anna Penalba Morenilla, Anna Bonaterra Pastra, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Maria Pilar Delgado Martínez, Jesús Pizarro Gonzálvez
Funding agency: Instituto de Salud Carlos III
Funding: 250214.8
Reference: RD21/0006/0007
Duration: 01/01/2022 - 31/12/2024

MULTI-BIO-TARGETS: una nueva estrategia para el manejo de ictus combinando biomarcadores pronósticos y neuroprotectores

IP: Olga Maisterra Santos
Collaborators: Joan Montaner Villalonga, Anna Penalba Morenilla, Paula Garcia Rodriguez
Funding agency: Instituto de Salud Carlos III
Funding: 363907.5
Reference: PI18/00804
Duration: 01/01/2019 - 30/06/2023

Discovery and clinical usefulness of blood biomarkers in stroke-associated pneumonia. The PROteomics and Transcriptomics in lEUkocyte Subpopulations (PROTEUS) study

IP: Olga Maisterra Santos
Collaborators: Bustamante Rangel, Alejandro, Joan Montaner Villalonga, Anna Penalba Morenilla
Funding agency: Fundació La Marató de TV3
Funding: 191375
Reference: 20170630
Duration: 01/01/2018 - 31/12/2021

STUDY OF THE MECHANISMS WITHIN THE ACUTE PHASE OF STROKE THAT ENHANCE THE DEVELOPMENT OF EPILEPSY

IP: José Alvarez Sabin
Collaborators: Anna Penalba Morenilla, LAURA ABRAIRA DEL FRESNO, Guillem Colell Dinares, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Fundació La Marató de TV3
Funding: 146034.29
Reference: 201702-30-31
Duration: 11/06/2018 - 11/02/2022

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Noelia Montoya Clemente

Noelia Montoya Clemente

Research technician
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Pau Bravo Aubeso

Pau Bravo Aubeso

Suport Recerca.Tècnic superor FPII
IT / Information Systems
Digital Transformation and Quality Area
Read more
Nuria  Martínez Sabaté

Nuria Martínez Sabaté

Administration and Management
Clinical Neuroimmunology
Read more
Gonzalo González Silva

Gonzalo González Silva

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.